MENTAL RETARDATION, AUTOSOMAL DOMINANT 20
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
MEF2C haploinsufficiency syndrome: Report of a new MEF2C mutation and review.
|
27255693 |
2016 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20
|
0.600 |
GeneticVariation
|
disease |
CLINVAR |
Molecular diagnostic experience of whole-exome sequencing in adult patients.
|
26633545 |
2016 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genome sequencing identifies major causes of severe intellectual disability.
|
24896178 |
2014 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
Refining the phenotype associated with MEF2C point mutations.
|
23001426 |
2013 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.
|
20513142 |
2010 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations.
|
19592390 |
2010 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations.
|
19592390 |
2010 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
Interstitial deletion 5q14.3-q21 associated with iris coloboma, hearing loss, dental anomaly, moderate intellectual disability, and attention deficit and hyperactivity disorder.
|
19876902 |
2009 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Status Epilepticus
|
0.500 |
Biomarker
|
disease |
RGD |
It was demonstrated that MEF2C is up-regulated during development (P0, P3, P7, P14 and P28) and in the adult rat dentate gyrus following SE (3, 7, 14, 28 days after SE).
|
18949272 |
2008 |
Status Epilepticus
|
0.500 |
Biomarker
|
disease |
CTD_human |
It was demonstrated that MEF2C is up-regulated during development (P0, P3, P7, P14 and P28) and in the adult rat dentate gyrus following SE (3, 7, 14, 28 days after SE).
|
18949272 |
2008 |
Autism Spectrum Disorders
|
0.410 |
CausalMutation
|
disease |
CLINVAR |
Targeted resequencing of 358 candidate genes for autism spectrum disorder in a Chinese cohort reveals diagnostic potential and genotype-phenotype correlations.
|
30763456 |
2019 |
Autism Spectrum Disorders
|
0.410 |
Biomarker
|
disease |
BEFREE |
Transcription factor MEF2C regulates multiple genes linked to autism spectrum disorder (ASD), and human MEF2C haploinsufficiency results in ASD, intellectual disability, and epilepsy.
|
29133852 |
2017 |
Autism Spectrum Disorders
|
0.410 |
Biomarker
|
disease |
CTD_human |
Here we present two additional patients with severe MR, autism spectrum disorder and epilepsy, carrying a very small deletion encompassing the MEF2C gene.
|
20412115 |
2010 |
Stereotypic Movement Disorder
|
0.400 |
Biomarker
|
phenotype |
CTD_human |
Refining the phenotype associated with MEF2C haploinsufficiency.
|
20412115 |
2010 |
Stereotypic Movement Disorder
|
0.400 |
Biomarker
|
phenotype |
HPO |
|
|
|
Epilepsy
|
0.370 |
Biomarker
|
disease |
BEFREE |
We aimed to delineate the spectrum of electroclinical manifestations of MEF2C-related epilepsy from an illustrative case and literature review.
|
30922778 |
2019 |
Intellectual Disability
|
0.370 |
AlteredExpression
|
group |
BEFREE |
Disruption of chromatin organisation causes MEF2C gene overexpression in intellectual disability: a case report.
|
31375103 |
2019 |
Intellectual Disability
|
0.370 |
Biomarker
|
group |
BEFREE |
Mef2c haploinsufficiency is implicated in behavioral deficits related to autism, schizophrenia, and intellectual disability.
|
30276662 |
2019 |
Epilepsy
|
0.370 |
Biomarker
|
disease |
CTD_human |
De novo variants in neurodevelopmental disorders with epilepsy.
|
29942082 |
2018 |
Epilepsy
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
The latter is a shift from current thinking, as MEF2C haploinsufficiency has been considered the main cause of epilepsy in 5q14.3 deletion syndrome.
|
29266188 |
2018 |
Epilepsy
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
The microRNAs target a group of genes enriched for synaptic signaling and epilepsy risk, including SLC12A5, SYT1, GRIN2A, GRIN2B, KCNB1, SCN2A, TSC1, and MEF2C.
|
28993242 |
2018 |
Intellectual Disability
|
0.370 |
GeneticVariation
|
group |
BEFREE |
Of these genes, point mutations in MEF2C cause a phenotype involving seizures and intellectual disability.
|
29266188 |
2018 |
Intellectual Disability
|
0.370 |
GeneticVariation
|
group |
BEFREE |
Overall, the MEF2C gene mutational analysis should be performed in ID cohort, especially in patients with features overlapped with RTT.
|
30376817 |
2018 |